Comparison between Advanta Enterprises IPO and Hindustan Laboratories IPO.
Advanta Enterprises IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Hindustan Laboratories IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advanta Enterprises IPO is up to ₹0.00 Cr whereas the issue size of the Hindustan Laboratories IPO is up to ₹0.00 Cr. The final issue price of Advanta Enterprises IPO is and of Hindustan Laboratories IPO is .
| Advanta Enterprises IPO | Hindustan Laboratories IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 50,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 3,61,05,578 shares | 91,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 3,61,05,578 shares | 1,41,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Advanta Enterprises IPO opens on , while Hindustan Laboratories IPO opens on . The closing date of Advanta Enterprises IPO and Hindustan Laboratories IPO is , and , respectively.
Advanta Enterprises IPO P/E ratio is , as compared to Hindustan Laboratories IPO P/E ratio of .
| Advanta Enterprises IPO | Hindustan Laboratories IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.21 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 93.86% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 52.67% | 33.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 38.33% | 26.11% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Advanta Enterprises IPO Retail Individual Investors (RII) are offered 0 shares while in Hindustan Laboratories IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Advanta Enterprises IPO and 0 shares in Hindustan Laboratories IPO.
| Advanta Enterprises IPO | Hindustan Laboratories IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Advanta Enterprises IPO subscribed in total, whereas Hindustan Laboratories IPO subscribed .
